Open AccessTargeted prostate biopsy: 68Ga-PSMA PET/CT vs. mpMRI in the diagnosis of prostate cancer
Author(s) -
Pietro Pepe,
Ludovica Pepe,
Maria Tamburo,
Giulia Marletta,
Michele Pennisi,
Filippo Fraggetta
Publication year - 2022
Publication title -
archivio italiano di urologia andrologia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.429
H-Index - 23
eISSN - 2282-4197
pISSN - 1124-3562
DOI - 10.4081/aiua.2022.3.274
Subject(s) - medicine , prostate cancer , prostate , biopsy , radiology , cancer , prostate biopsy , urology , oncology
To evaluate the diagnostic accuracy of 68Ga-prostate-specic membrane antigen (PSMA) positron emission tomography/computed tomog-raphy (PET/CT) vs. multiparametric magnetic resonance imaging (mpMRI) targeted biopsy (TPBx) in the diagnosis of clinical-ly signicant prostate cancer (csPCa: Grade Group ≥ 2).